Q3 2023

Filed Nov 17, 2023 · 10-Q · 48 days after period end · 0001493152-23-041854

Q3 2023 · 10-Q

Revenue—

Net Income

-$1.10M

N/M vs Q3 2022

EPS Diluted

-$0.02

N/M vs Q3 2022

Operating Income-$548,429N/M

Operating Cash Flowderived-$72,362N/M

Same quarter

Metric	Q3 2023	Q3 2022	Q3 2021	Q3 2013
Revenue	—	—	—	$139.98K
Net Income	-$1.10M	-$295.27K	-$331.72K	$8.21M
EPS Diluted	-$0.02	-$0.01	—	$0.36

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

NovelStem International Corp. · CIK 912544 · Engraved from SEC EDGAR